Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
1532141
Reference Type
Journal Article
Title
Treatment strategies for diabetic patients suffering from erectile dysfunction
Author(s)
Chen, Yun; Dai, Y; Wang, Run
Year
2008
Is Peer Reviewed?
1
Journal
Expert Opinion on Pharmacotherapy
ISSN:
1465-6566
EISSN:
1744-7666
Volume
9
Issue
2
Page Numbers
257-266
PMID
18201148
DOI
10.1517/14656566.9.2.257
Web of Science Id
WOS:000252878400008
Abstract
Erectile dysfunction is a common complication of diabetes.
Clinical practice has no treatment modality specifically designed for the difficult to treat
diabetic erectile dysfunction due to the multifactorial and complex pathophysiology of
development. PDE type 5 inhibitors are the first-line treatment option. Non-responders should
have total and free testosterone checked and testosterone replacement is recommended for
hypogonadal patients. For patients who cannot take PDE type 5 inhibitors, or are proven non-
responders, the vacuum constriction device continues to serve as a major treatment option.
Intracavernosal injection is the most effective medical therapy for diabetic erectile dysfunction
despite its high dropout rate. Use of the Medicated Urethral System for Erection to overcome the
disadvantages of needle injection is disappointing due to lack of effectiveness. Penile
prosthesis will continue to play an important role in diabetic patients with severe erectile
dysfunction in coming years.
Keywords
diabetes; erectile dysfunction; treatment
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity